ESTROGENIC SUBSTANCE Drug Patent Profile
✉ Email this page to a colleague
When do Estrogenic Substance patents expire, and when can generic versions of Estrogenic Substance launch?
Estrogenic Substance is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in ESTROGENIC SUBSTANCE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESTROGENIC SUBSTANCE?
- What are the global sales for ESTROGENIC SUBSTANCE?
- What is Average Wholesale Price for ESTROGENIC SUBSTANCE?
Summary for ESTROGENIC SUBSTANCE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Patent Applications: | 3,232 |
| DailyMed Link: | ESTROGENIC SUBSTANCE at DailyMed |
US Patents and Regulatory Information for ESTROGENIC SUBSTANCE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ESTROGENIC SUBSTANCE | estrone | INJECTABLE;INJECTION | 083488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
